Harvard Bioscience Inc reports results for the quarter ended in March - Earnings Summary

Harvard Bioscience

04/05/2022 19:04

* Harvard Bioscience Inc  HBIO.OQ  reported quarterly
adjusted
earnings of 4 cents​​ per share for the quarter ended in March.
The mean expectation of four analysts for the quarter was
for earnings of 5 cents per share.
    * Revenue rose 6.6% to $28.78 million from a year ago; 
analysts
expected $28.77 million. 
    * Harvard Bioscience Inc's reported EPS for the quarter was
a loss
of 17 cents​.
    * The mean earnings estimate of analysts had fallen by
about 3% in
the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Harvard Bioscience Inc shares had fallen by 9.0% this
quarter and lost 19.9% so far this year.
    * The company reported a quarterly loss of $6.88 million.
    * Wall Street's median 12-month price target for Harvard
Bioscience Inc is $10.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 4 at 06:03 p.m.  ​All
figures in US dollars unless otherwise stated